Cell Design Labs: Cell Design sells to Gilead in $567m deal
The transaction includes a 12.2% stake in Cell Design held by Kite Pharma, which Gilead bought for $11.9bn in October this year.
Read full article »
Co-Founder & CEO
Brian Atwood
Cell Design Labs focuses on developing CAR-T and T cell receptor therapies for the treatment of cancer.
Read more